| 85.86 |  +1.04 / +1.23% |
Data as of Jun 18 | Day’s Change |
| 86.00 | +0.14 / +0.16% |
Volume: 26.6K |
| The Top 3 Medical Uses of Botox Jun 18 / MotleyFool.com | This Company is Set for Newer Heights in the Eye-Care Sector Jun 11 / MotleyFool.com |
| UPDATE: Valeant Pharmaceuticals Announces Public Offering Of Common Shares; To Raise ... Jun 17 / Benzinga | Hyperion Acquires Buphenyl Rights - Analyst Blog Jun 10 / Zacks.com |
| Warner Chilcott: Should You Buy Joel Greenblatt's Latest Pick? Jun 13 / MotleyFool.com | 2 Huge Deals as M&A Accelerates Jun 06 / MotleyFool.com |
| Valeant Biting More Than it Can Chew Jun 13 / MotleyFool.com | Stocks: Housing data helps rally May 28 / CNNMoney.com |
| Tme to Buy This Defensive Growth Stock? Jun 11 / MotleyFool.com | Valeant pays $8.7 billion for Bausch & Lomb May 27 / CNNMoney.com |
| Previous close | 84.82 |
| Today’s open | 84.11 |
| Day’s range | -- - -- |
| Volume | 2,443,519 |
| Average volume (3 months) | 1,755,968 |
| Market cap | $26.2B |
| Dividend yield | -- |
| Earnings growth (last year) | -173.08% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +11.50% |
| Revenue growth (last year) | +43.97% |
| P/E ratio | 27.4 |
| Price/Sales | 5.15 |
| Price/Book | 7.02 |
| Today’s change | Today’s % change | |
|---|---|---|
| AGNAllergan Inc | +0.01 | +0.01% |
| SHPGShire PLC | -0.03 | -0.03% |
| ALXNAlexion Pharmaceutic... | +1.07 | +1.17% |
| VRTXVertex Pharmaceutica... | +0.05 | +0.06% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $3.5B |
| Annual profit (last year) | -$116.0M |
| Net profit margin | -3.27% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer J. Michael Pearson, MBA |
Chief Financial Officer, Director & Executive VP Howard Bradley Schiller |
Corporate headquarters Montréal, Québec |
.
